Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hecquet

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Bulletin Du Cancer|January 1, 1994
[New molecules with potential antitumor effect]B Hecquet
Bulletin Du Cancer|January 1, 1988
[Animal pharmacokinetics in the quantitative estimation of clinical pharmacokinetics of antitumor agents]B Hecquet
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Chronoavailability: a theoretical method of studying chronopharmacology]B Hecquet
Bulletin Du Cancer|December 1, 1995
[Contribution of computers to pharmacokinetics, Bayesian approach and population pharmacokinetics]B Hecquet
Pathologie-Biologie|June 1, 1987
[Modeling in chronopharmacology]B Hecquet
Chronobiology International|January 1, 1986
Constant pharmacologic effect and chronopharmacology: theoretical aspectsB Hecquet
Pathologie-Biologie|December 1, 1988
[Plasma, renal and tumor determination of total platinum during predictive tests of chemosensitivity of human tumor implants in the renal capsule in syngeneic mice]R Favre, B Hecquet
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1986
Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curveB Hecquet, M Sucche
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomized studyJ Bonneterre, B Hecquet
LARC Medical|September 1, 1982
[The natriuretic factor (natriuresis, natriuretic factor, natriuretic hormone)]B Hecquet, J Lefebvre
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Bulletin Du Cancer|January 1, 1994
[New molecules with potential antitumor effect]B Hecquet
Bulletin Du Cancer|January 1, 1988
[Animal pharmacokinetics in the quantitative estimation of clinical pharmacokinetics of antitumor agents]B Hecquet
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Chronoavailability: a theoretical method of studying chronopharmacology]B Hecquet
Bulletin Du Cancer|December 1, 1995
[Contribution of computers to pharmacokinetics, Bayesian approach and population pharmacokinetics]B Hecquet
Pathologie-Biologie|June 1, 1987
[Modeling in chronopharmacology]B Hecquet
Chronobiology International|January 1, 1986
Constant pharmacologic effect and chronopharmacology: theoretical aspectsB Hecquet
Pathologie-Biologie|December 1, 1988
[Plasma, renal and tumor determination of total platinum during predictive tests of chemosensitivity of human tumor implants in the renal capsule in syngeneic mice]R Favre, B Hecquet
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1986
Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curveB Hecquet, M Sucche
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomized studyJ Bonneterre, B Hecquet
LARC Medical|September 1, 1982
[The natriuretic factor (natriuresis, natriuretic factor, natriuretic hormone)]B Hecquet, J Lefebvre
Pageof 9